Eden closes $22 million Series A round led by global funds

The round, led by Sierra Ventures, Liquid 2 Ventures and Daniel Servitje, will help Eden achieve expansion into key markets such as the United States

In what is one of the largest rounds for a healthtech in Latin America, Eden, a radiology operating system that facilitates access to healthcare for more than 2,200 medical institutions in Latin America, today announced the closing of a $22 million Series A investment round. The round was led by Sierra Ventures, Liquid 2 Ventures and Daniel Servitje, CEO of Grupo Bimbo.

This year has been particularly positive for healthtech, a sector of startups that usually attracts smaller investment rounds. In September 2025, Osigu, founded by Guatemalan Fernando Botran, received a US$10 million check in venture capital. It is worth noting that Osigu is also in the fintech field, as it is a platform that seeks to digitize and streamline the payment infrastructure between insurers, healthcare providers and patients in the region.

For its part, Eden, founded by Mexican Julián Ríos, has always been in the healthtech arena. The startup has received investment rounds from funds such as Khosla Ventures (fund behind OpenAI) and Kaszek Ventures (founders of Mercado Libre), as well as strategic investors such as Leonardo DiCaprio, Ashton Kutcher and Tony Robbins.

“We are consolidating a world-class radiology operating system for all of Latin America, where unequal access to quality diagnostics should no longer obstruct the work of specialists. This investment validates not only Eden’s technological potential in markets such as the United States, but also the urgency of our mission: to bring high-standard medical care to all, without exception. We are proud to have the support of global partners who share our vision and commitment to health equity,” said Rios, CEO of Eden.

The evolution of Eden

Julian Rios started his entrepreneurship journey at the young age of 17. In 2015 he launched Eva, a device that helped detect breast cancer, which his mother suffered from, and eventually evolved into detecting other diseases. In an interview in 2017, he already envisioned this transformation, as Ríos lamented that “in Mexico there is a lack of radiologists and thermographers” to detect diseases in time.

By 2022, Ríos guided Eden towards a new business model related entirely to radiology. In 2024 he announced that this Mexican healthtech aimed at digitizing X-ray analysis closed a $10 million investment round (it had already raised around $25 million). The round was led by Sierra Ventures, together with Dalus Capital, Alt Capital, Liquid2 and Endeavor.

The solution was already used by companies such as Grupo Diagnóstico PROA, Laboratorios del Chopo, Grupo Santa María, Lapi Laboratorio and Imagenología Christus Muguerza.

The funds raised today will allow Eden to accelerate its regional expansion, invest in technological development with a focus on leading in AI and scale its clinical impact in new strategic markets.

With a presence in 18 countries and benefiting more than 13 million patients annually, Eden operates through a cloud-native RIS/PACS system that integrates advanced diagnostic tools with the power of artificial intelligence, empowering radiologists and improving the accuracy and speed of medical diagnoses throughout the region.

Recently, Eden launched AI Report, a platform based on the use of collaborative artificial intelligence for the creation of clinical reports in radiology. This new tool allows radiologists to dictate their interpretations aloud while viewing medical images, automatically generating complete, accurate clinical reports tailored to each specialist’s workflow.